Hercules Technology Growth Capital, Inc. (NASDAQ:HTGC) ("Hercules”)
announced the closing of its public offering. The underwriter purchased
5,000,000 shares of common stock from Hercules in a bought deal for a
price equal to its last published net asset value of $9.61 per share,
resulting in proceeds of $48,050,000 before deducting offering expenses.
The last reported sales price of Hercules’ common stock on January 19,
2012 prior to the sale of its shares of common stock was $10.25 per
share.
Hercules has granted the underwriter a 30-day option to purchase up to
an additional 750,000 shares of common stock.
Hercules expects to use the net proceeds from this offering to fund
investments in debt and equity securities in accordance with its
investment objective and for other general corporate purposes.
Citigroup is the sole underwriter of this offering.
The securities described above were offered by Hercules pursuant to an
effective shelf registration statement. The offering may be made only by
means of a prospectus supplement and the accompanying prospectus, copies
of which may be obtained from Citigroup, Brooklyn Army Terminal, 140
58th Street, 8th Floor, Brooklyn, New York 11220 (telephone number:
1-800-831-9146).
Investors are advised to carefully consider the investment objectives,
risks, and charges and expenses of Hercules before investing. The
prospectus, which has been filed with the Securities and Exchange
Commission, contains this and other information about Hercules and
should be read carefully before investing.
This press release shall not constitute an offer to sell or the
solicitation of an offer to buy, nor shall there be any sale of, the
shares in any state or other jurisdiction in which such offer,
solicitation or sale would be unlawful prior to the registration or
qualification under the securities laws of any such state or other
jurisdiction.
About Hercules Technology Growth Capital, Inc.:
Hercules Technology Growth Capital, Inc. is a Nasdaq traded specialty
finance firm providing customized loans to public and private companies
in the technology, clean technology, and life science industries, at all
stages of development.
Forward-Looking Statements:
The statements contained in this release that are not purely historical
are forward-looking statements. These forward-looking statements are not
guarantees of future performance and are subject to uncertainties and
other factors that could cause actual results to differ materially from
those expressed in the forward-looking statements including, without
limitation, the risks, uncertainties and other factors we identify from
time to time in our filings with the Securities and Exchange Commission.
Although we believe that the assumptions on which these forward-looking
statements are based are reasonable, any of those assumptions could
prove to be inaccurate and, as a result, the forward-looking statements
based on those assumptions also could be incorrect. You should not place
undue reliance on these forward-looking statements. The forward-looking
statements contained in this release are made as of the date hereof, and
Hercules assumes no obligation to update the forward-looking statements
for subsequent events.
